Skip to main content

Clinical research for health care.

Another important advance in the prevention of RSV
of RSV disease

The FDA approved ENFLONSIA™, a preventive monoclonal antibody against respiratory syncytial virus (RSV) developed by MSD. Once again, Equipo Ciencia participated in the clinical study in 3 centers in CABA, Córdoba and MDQ.

Argentina marks global milestone in RSV prevention with maternal vaccination
with maternal vaccination

In April 2025, the prestigious scientific journal The Lancet Infectious Diseases published the results of the BERNI study, which evaluated for the first time in the world the effectiveness of the maternal vaccine against respiratory syncytial virus (RSV) at the national level and under real-life conditions.

Participation is
always voluntary.

Participants remain in the
study for as long as they wish.

It is a priority to preserve the safety
of the participants.

There is no cost
to volunteer.

Participation is
always voluntary.

Participants remain in the
study for as long as they wish.

It is a priority to preserve the safety
of the participants.

There is no cost
to volunteer.

I want to participate

Active Studies

Future Studies

I want to participate

Active Studies

Future Studies

Clinical research is synonymous with scientific progress.

Do you want to be part of the next clinical trials against the most important diseases?

We invite you to join us!

Do you want to be part of upcoming clinical trials against major diseases?

We invite you to join us!